Hendon Partners

Industry Verticals

5 articles on industry verticals from Hendon Partners' home care M&A advisory team.

Industry Verticals

DME Company M&A in 2026: Valuations, Buyers, and What's Driving Deal Activity

Durable medical equipment M&A activity has accelerated as PE platforms and strategics consolidate the highly fragmented DME, respiratory, and complex rehab markets. Here is what DME owners should know about selling in 2026.

May 4, 2026

Industry Verticals

Adult Day Health Center Valuation & M&A in 2026: An Underexplored Exit Opportunity

Adult day health centers and adult day programs are an undercovered M&A niche with strong demographic tailwinds and emerging buyer interest. Here is what owners should know about valuations and exit options in 2026.

May 4, 2026

Industry Verticals

Palliative Care Agency Valuation & M&A in 2026: Distinguished from Hospice, Different Multiples

Palliative care is rapidly emerging as a distinct M&A category — different from hospice in payer mix, clinical model, and valuation. Here is what palliative care agency owners should know about selling in 2026.

May 4, 2026

Industry Verticals

Infusion Pharmacy & Home Infusion M&A in 2026: Valuations, Buyers, and What PE Is Paying

Home infusion and specialty infusion pharmacy M&A activity has accelerated meaningfully in 2026. Here is what owners of home infusion, ambulatory infusion, and specialty pharmacy platforms should know about valuations, active buyers, and deal mechanics.

May 4, 2026

Industry Verticals

Addiction Treatment & Substance Abuse M&A in 2026: Valuations, Buyers, and Deal Drivers

Addiction treatment and substance use disorder M&A activity has accelerated sharply in 2026. Here is what owners of MAT clinics, residential, IOP, and PHP programs should know about valuations, active buyers, and deal mechanics.

May 4, 2026